在先进的肺瘤中,ALCAM介导的cDC1 CD8 T细胞相互作用被抑制
Luciano G Morosi1, Giulia M Piperno1, Lucía López1
1Cellular Immunology, International Centre for Genetic Engineering and Biotechnology (ICGEB), Trieste, Italy.
Oncoimmunology
|June 18, 2024
概括
激活白细胞细胞粘附分子 (ALCAM) 在早期肺癌中稳定了树突细胞和T细胞之间的关键相互作用. 在晚期瘤中降低它的调节促进了免疫逃避.
科学领域:
- 免疫学 免疫学 免疫学
- 癌症生物学 癌症生物学
- 细胞相互作用 细胞相互作用
背景情况:
- 传统的1型树突细胞 (cDC1) 是抗瘤T细胞反应的关键调节者.
- 对cDC1-CD8 T细胞相互作用的稳定性对于抗瘤免疫至关重要,但对癌症进展的理解不足.
研究的目的:
- 研究在非小细胞肺癌进展过程中控制cDC1-CD8 T细胞相互作用的分子机制.
- 确定稳定或破坏这些关键免疫细胞接触的因素.
主要方法:
- 用光cDC1记者 (KP-XCR1venus) 来生成非小细胞肺癌的遗传模型.
- 在不同阶段的瘤中分析cDC1-CD8 T细胞群.
- 转录造型和流细胞计.
- 对人类非小细胞肺癌数据集的分析.
主要成果:
- 在早期瘤中,cDC1-CD8 T 细胞群丰富,但在晚期瘤中减少.
- 激活的白细胞细胞粘附分子 (ALCAM/CD166) 在早期瘤中被cDC1高度表达,并在晚期瘤中下调.
- 在非小细胞肺癌中ALCAM下调与人类数据集中更差的预后相关.
- ALCAM的参与促进了cDC1-CD8 T细胞接触形成和T细胞激活,而阻断则抑制了它.
结论:
- 在早期肺癌中,ALCAM对于稳定cDC1-CD8T细胞相互作用至关重要.
- 在晚期瘤中失去ALCAM有助于免疫逃避和降低抗瘤免疫力.
- 阿尔卡姆是增强抗瘤反应的潜在治疗标.
相关概念视频
Inhibition of Cdk Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.


